Epigenetic modulation of immunotherapy and implications in head and neck cancer

Cancer progression is facilitated by distinct mechanisms developed by cancer cells to avoid immune recognition and clearance. The clinical application of immune checkpoint blockade (ICB), via monoclonal antibodies blocking PD-1/PD-L1 and CTLA4, has achieved promising durable therapeutic response in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liye, Xu, Na, Shibata, Hirofumi, Saloura, Vassiliki, Uppaluri, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Non-Thematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897200/
https://www.ncbi.nlm.nih.gov/pubmed/33403469
http://dx.doi.org/10.1007/s10555-020-09944-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897200/
https://www.ncbi.nlm.nih.gov/pubmed/33403469
http://dx.doi.org/10.1007/s10555-020-09944-0

Ejemplares similares